MedTrace Logo

The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection

NCT05620589 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 626

Last updated 2022-11-17

No results posted yet for this study

Summary

The researchers collect patients who accepted eradication program of the helicobacter pylori but failed to eradicate helicobacter pylor from the outpatient clinic. After rescue therapy, evaluating the effect of retreatment interval on eradication effect of Helicobacter pylori infection.

Conditions

  • Helicobacter Pylori Infection

Interventions

DRUG

Amoxicillin + Tetracycline + Bismuth + Esomeprazole

Amoxicillin 1000mg bid+ Tetracycline 500mg qid+ Bismuth + Esomeprazole 40mg bid or Amoxicillin 1000mg bid+ Tetracycline 500mg tid+ Bismuth + Esomeprazole 40mg bid

DRUG

Amoxicillin + Tetracycline + Bismuth + Vonoprazan

Amoxicillin 1000mg bid+ Tetracycline 500mg qid+ Bismuth +Vonoprazan 20mg bid or Amoxicillin1000mg bid+ Tetracycline 500mg tid+ Bismuth + Vonoprazan 20mg bid

DRUG

Amoxicillin + Tetracycline + Bismuth + Tegoprazan

Amoxicillin 1000mg bid+ Tetracycline 500mg qid+ Bismuth + Tegoprazan 50mg bid or Amoxicillin 1000mg bid+ Tetracycline 500mg tid+ Bismuth + Tegopraza 50mg bid

Sponsors & Collaborators

  • Peking University Care Luzhong Hospital

    collaborator OTHER

  • Yuncheng Traditional Chinese Medicine Hospital

    collaborator OTHER

  • Taierzhuang District People's Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER

  • Zibo Central Hospital

    collaborator OTHER_GOV

  • Shandong University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-11
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05620589 on ClinicalTrials.gov